Scholar Rock Holding Corporation (SRRK)
SRRK price $43.00 +1.64 +3.97%
- Ticker
- SRRK
- Price
- $43.00
- Change
- +1.64 +3.97%
- Market cap
- $5.24B
- P/E
- -12.50
- Forward P/E
- 843.68
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 65
Scholar Rock Holding Corporation is a biopharmaceutical firm dedicated to discovering and advancing treatments for severe medical conditions by targeting the crucial role of protein growth factor signaling. Their lead therapeutic candidate, Apitegromab, an agent designed to inhibit the activation of latent myostatin, has successfully concluded Phase 3 clinical trials for spinal muscular atrophy (SMA). Another key…